Is CCAP or CET more undervalued in 2026?

CirclFi compares Crescent Capital BDC, Inc. (CCAP) and 11017 (CET) using 13 institutional-grade valuation models. CCAP has a Quality of Company score of 5.3/10 while CET scores 2.0/10.

Which is a better buy — CCAP or CET?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CCAP and CET valuations compare?

CCAP at $11.45 and CET at $53.10 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CCAP vs CET Valuation Comparison 2026 — Intrinsic Value Analysis

CCAP

Asset Management

Crescent Capital BDC, Inc.

Quality

5.3

out of 10

Value Trap

SAFE

Price

$11.45

Last close

Models

9/13

Active

CET

Asset Management

11017

Quality

2.0

out of 10

Value Trap

—

Price

$53.10

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	CCAP Fair Value	CCAP Upside	CET Fair Value	CET Upside
Bayesian DCF	Intrinsic	$32.92	+187.5%	$14.06	-73.5%
Earnings Power Value	Intrinsic	—	—	$21.14	-60.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$29.07	+153.9%	$295.84	+457.1%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CCAP vs CET — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CCAP vs CET — Which Stock Is More Undervalued?

CCAP scores higher with a 5.3/10 quality rating vs CET's 2.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Crescent Capital BDC, Inc. (CCAP) and 11017 (CET) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CCAP currently trades at $11.45 with a QOC of 5.3/10, while CET trades at $53.10 with a QOC of 2.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).